diminazene has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, TL; Mayence, A; Vanden Eynde, JJ | 1 |
Cheang, WS; Huang, Y; Lan, HY; Lau, CW; Liu, J; Luo, JY; Raizada, MK; Tian, XY; Wang, L; Wong, CM; Wong, WT; Xu, J; Yao, X; Zhang, Y | 1 |
1 review(s) available for diminazene and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Some non-conventional biomolecular targets for diamidines. A short survey.
Topics: Amidines; Animals; Diabetes Mellitus, Type 2; DNA; Enzymes; Humans; Hypertension; Ion Channels; Myotonic Dystrophy; Neoplasms; Neurodegenerative Diseases; Proteins; RNA; Thrombosis | 2014 |
1 other study(ies) available for diminazene and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
Topics: Acetylcholine; Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Aorta; Cells, Cultured; Diabetes Mellitus, Type 2; Diminazene; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred C57BL; Middle Aged; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renal Artery; Up-Regulation; Vasodilator Agents | 2015 |